A Study of Pipeline Drugs in Neuroendocrine Tumors (Q84070923)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

A study of pipeline drugs in neuroendocrine tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

A Study of Pipeline Drugs in Neuroendocrine Tumors (English)

1 reference

https://api.crossref.org/works/10.1007/S12029-011-9286-9

1 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21556722

antitumor drug screening assay

1 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21556722

1 December 2024

author name string

John Lyons

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Peter Casey

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jennifer Abadie

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yi-Zarn Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Catherine T. Anthony

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21556722

1 December 2024

Juan G. Bastidas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21556722

1 December 2024

Jessica L. Thomson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21556722

1 December 2024

James M. Lewis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21556722

1 December 2024

Joshua E. Schwimer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21556722

1 December 2024

Daniel J. Frey

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21556722

1 December 2024

J. Philip Boudreaux

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21556722

1 December 2024

Eugene A. Woltering

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21556722

1 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21556722

1 December 2024

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

June 2012

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21556722

full work available at URL

1 December 2024

https://link.springer.com/content/pdf/10.1007/s12029-011-9286-9.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S12029-011-9286-9

https://link.springer.com/article/10.1007/s12029-011-9286-9/fulltext.html

1 December 2024

1 reference

https://api.crossref.org/works/10.1007/S12029-011-9286-9

http://link.springer.com/content/pdf/10.1007/s12029-011-9286-9

1 December 2024

1 reference

https://api.crossref.org/works/10.1007/S12029-011-9286-9

Journal of gastrointestinal cancer

1 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

296-304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

EPCs and pathological angiogenesis: when good cells go bad.

31 January 2020

cites work

1 reference

12 December 2020

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study

1 reference

12 December 2020

Clinical and in vitro studies of imatinib in advanced carcinoid tumors

1 reference

12 December 2020

Metabolism and disposition of vatalanib (PTK787/ZK-222584) in cancer patients

1 reference

12 December 2020

Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors

1 reference

12 December 2020

Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line

1 reference

12 December 2020

Endothelial/pericyte interactions

1 reference

12 December 2020

Genes that distinguish physiological and pathological angiogenesis

1 reference

12 December 2020

Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.

1 reference

12 December 2020

New drugs for breast cancer

1 reference

12 December 2020

Metronomic dosing enhances the anti-angiogenic effect of epothilone B.

1 reference

12 December 2020

1 reference

12 December 2020

Tyrosine kinases as targets for cancer therapy

1 reference

12 December 2020

SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs

1 reference

12 December 2020

Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.

1 reference

12 December 2020

A new in vitro assay for human tumor angiogenesis: three-dimensional human tumor angiogenesis assay

1 reference

12 December 2020

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

1 reference

12 December 2020

Effect of human Angiostatin protein on human angiogenesis in vitro

1 reference

12 December 2020

Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib

1 reference

12 December 2020

Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors

1 reference

12 December 2020

EPO906 (epothilone B): a promising novel microtubule stabilizer

1 reference

12 December 2020

New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspective

1 reference

12 December 2020

The role of angiogenesis in neuroendocrine tumors

1 reference

12 December 2020

Development of a human cardiac tissue-based angiogenesis model.

1 reference

12 December 2020

A critical analysis of current in vitro and in vivo angiogenesis assays

1 reference

12 December 2020

The TOR pathway: a target for cancer therapy

1 reference

12 December 2020

Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors.

1 reference

12 December 2020

Growing vascular endothelial cells express somatostatin subtype 2 receptors

1 reference

12 December 2020

Tumor angiogenesis: a possible control point in tumor growth

1 reference

12 December 2020

Somatostatin receptor type 5 modulates somatostatin receptor type 2 regulation of adrenocorticotropin secretion.

1 reference

12 December 2020

The biology of VEGF and its receptors

1 reference

12 December 2020

Molecular basis of angiogenesis and cancer

1 reference

12 December 2020

Functional endocrine tumors of the pancreas: clinical presentation, diagnosis, and treatment

1 reference

12 December 2020

A mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progression

1 reference

12 December 2020

Effect of human recombinant Endostatin protein on human angiogenesis

1 reference

12 December 2020

1 reference

12 December 2020

Mechanisms of angiogenesis and arteriogenesis

1 reference

12 December 2020

Angiogenesis inhibitors: current strategies and future prospects

1 reference

12 December 2020

The epothilones: translating from the laboratory to the clinic

1 reference

12 December 2020

Pericytes and vessel maturation during tumor angiogenesis and metastasis

1 reference

12 December 2020

Targeting mTOR for cancer treatment.

1 reference

12 December 2020

The North American Neuroendocrine Tumor Society (NANETS) Guidelines

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly

1 reference

12 December 2020

Role of angiogenesis in tumor growth and metastasis

1 reference

12 December 2020

A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer

1 reference

12 December 2020

Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action

1 reference

12 December 2020

Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors

1 reference

12 December 2020

Primetime for antiangiogenic therapy

1 reference

12 December 2020

Development of a novel in vitro human tissue-based angiogenesis assay to evaluate the effect of antiangiogenic drugs

1 reference

12 December 2020

Breast cancer increases initiation of angiogenesis without accelerating neovessel growth rate

1 reference

12 December 2020

Clinical presentation and management of carcinoid tumors

1 reference

12 December 2020

Recombinant vascular basement membrane derived multifunctional peptide blocks endothelial cell angiogenesis and neovascularization

1 reference

12 December 2020

1 reference

12 December 2020

Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system

1 reference

12 December 2020

Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy

1 reference

12 December 2020

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

1 reference

12 December 2020

Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.

1 reference

12 December 2020

Expression of vascular endothelial growth factor in digestive neuroendocrine tumours

1 reference

12 December 2020

Pharmacological Reviews

33

52

237

AW Griffiden

2000

1 reference

https://api.crossref.org/works/10.1007/S12029-011-9286-9

Journal of Clinical Oncology

1 December 2024

57

25

18S

LB Anthony

2007

1 reference

https://api.crossref.org/works/10.1007/S12029-011-9286-9

Journal of Clinical Oncology

1 December 2024

58

22

352

L Anthony

2003

1 reference

https://api.crossref.org/works/10.1007/S12029-011-9286-9

1 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21556722%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference